HLOSF (Healios KK) Total Stockholders Equity: $47.56 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HLOSF Healios KK HLOSF
51 GF Score
Price $1.80
GF Value $0.41
! 5 Warning Signs
View Full Analysis

What is Healios KK Total Stockholders Equity?

Healios KK HLOSF 51 Total Stockholders Equity is $47.56 Mil as of Mar. 2026. GuruFocus rates HLOSF with a GF Score™ of 51/100 and a GF Value™ of $0.41. The stock has 5 warning signs investors should review.

Healios KK's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $47.56 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Healios KK's Book Value per Share for the quarter that ended in Mar. 2026 was $0.35. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Healios KK's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.34.

Healios KK  (OTCPK:HLOSF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Healios KK's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(47.56-0)/135.002
=0.35

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Healios KK's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3.718 + 12.597) / 47.56
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healios KK Total Stockholders Equity Related Terms

Healios KK Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Healios KK's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healios KK Total Stockholders Equity Chart

Healios KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.89 32.48 26.78 13.41 31.36

Healios KK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.12 8.69 19.85 31.36 47.56
HLOSF
51GF Score
Healios KK HLOSF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $47.56 Mil mean?
Healios KK (HLOSF) has a Total Stockholders Equity of $47.56 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Healios KK and its competitors.
Is Healios KK's Total Stockholders Equity too high?
Healios KK's current Total Stockholders Equity is $47.56 Mil. Overall, Healios KK has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Healios KK's Total Stockholders Equity compare to VRTX and REGN?
Healios KK's Total Stockholders Equity of $47.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Healios KK and its competitors. Healios KK's current Total Stockholders Equity is $47.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healios KK stock overvalued right now?
Healios KK (HLOSF) has a current Total Stockholders Equity of $47.56 Mil. The stock's GF Value™ is $0.41, compared to a current price of $1.80 — trading 339% above its estimated fair value. The current Total Stockholders Equity is $47.56 Mil. Healios KK's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Healios KK (HLOSF), the current Total Stockholders Equity is $47.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healios KK (HLOSF) Overvalued in 2026?

Based on GuruFocus' analysis, Healios KK stock appears to be overvalued. The current stock price of $1.80 is trading 339% above its estimated GF Value™ of $0.41.

Key valuation signals for HLOSF:

  • Total Stockholders Equity: $47.56 Mil
  • GF Value™: $0.41 vs. price of $1.80 (339% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the HLOSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healios KK Business Description

Other Exchanges 4593:Japan6VX:Germany
Address 1-1-2 Yurakucho, Hibiya Mitsui Tower 12Floor, Work Styling, Chiyoda-ku, Tokyo, JPN, 100-0006
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy. The company develops next-generation cell therapies using a proprietary gene-edited induced pluripotent stem cell (iPSC) platform, with programs targeting immuno-oncology, ophthalmology, liver diseases, ischemic stroke, and acute respiratory distress syndrome.
51GF Score

Get the complete analysis for HLOSF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.80
Price
$0.41
GF Value